Molecular Identification of Zygomycetes from Culture and Experimentally Infected Tissues
Open Access
- 1 February 2006
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 44 (2) , 340-349
- https://doi.org/10.1128/jcm.44.2.340-349.2006
Abstract
Mucormycosis is an emerging infection associated with a high mortality rate. Identification of the causative agents remains difficult and time-consuming by standard mycological procedures. In this study, internal transcribed spacer (ITS) sequencing was validated as a reliable technique for identification of Zygomycetes to the species level. Furthermore, species identification directly from infected tissues was evaluated in experimentally infected mice. Fifty-four Zygomycetes strains belonging to 16 species, including the most common pathogenic species of Rhizopus spp., Absidia spp., Mucor spp., and Rhizomucor spp., were used to assess intra- and interspecies variability. Ribosomal DNA including the complete ITS1-5.8S-ITS2 region was amplified with fungal universal primers, sequenced, and compared. Overall, for a given species, sequence similarities between isolates were >98%. In contrast, ITS sequences were very different between species, allowing an accurate identification of Zygomycetes to the species level in most cases. Six species ( Rhizopus oryzae , Rhizopus microsporus , Rhizomucor pusillus , Mucor circinelloides , and Mucor indicus ) were also used to induce disseminated mucormycosis in mice and to demonstrate that DNA extraction, amplification of fungal DNA, sequencing, and molecular identification were possible directly from frozen tissues.Keywords
This publication has 35 references indexed in Scilit:
- Zygomycosis in a Tertiary‐Care Cancer Center in the Era ofAspergillus‐Active Antifungal Therapy: A Case‐Control Observational Study of 27 Recent CasesThe Journal of Infectious Diseases, 2005
- Breakthrough Fungal Infections in Stem Cell Transplant Recipients Receiving VoriconazoleClinical Infectious Diseases, 2004
- Breakthrough Zygomycosis after Voriconazole Treatment in Recipients of Hematopoietic Stem-Cell TransplantsNew England Journal of Medicine, 2004
- Experience with the MicroSeq D2 Large-Subunit Ribosomal DNA Sequencing Kit for Identification of Filamentous Fungi Encountered in the Clinical LaboratoryJournal of Clinical Microbiology, 2004
- Activity of Posaconazole in Treatment of Experimental Disseminated ZygomycosisAntimicrobial Agents and Chemotherapy, 2003
- Apophysomyces elegans : an Emerging Zygomycete in IndiaJournal of Clinical Microbiology, 2003
- In Vitro Activities of Posaconazole, Itraconazole, Voriconazole, Amphotericin B, and Fluconazole against 37 Clinical Isolates of ZygomycetesAntimicrobial Agents and Chemotherapy, 2002
- Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant RecipientsClinical Infectious Diseases, 2002
- Medical mycologyRevista do Instituto de Medicina Tropical de São Paulo, 1992
- Avoiding false positives with PCRNature, 1989